Your browser doesn't support javascript.
loading
Efficacy and acceptability of treatment to eradicate nasal Staphylococcus aureus carriage among haemodialysis patients.
Ritchie, Stephen R; Burrett, Emma; Priest, Patricia; Drown, Juliet; Taylor, Susan; Wei, Jason; Collins, John; Thomas, Mark G.
Afiliação
  • Ritchie SR; School of Medical Sciences, University of Auckland, Dunedin, New Zealand.
  • Burrett E; Infectious Disease Department, Auckland District Health Board, Dunedin, New Zealand.
  • Priest P; School of Medical Sciences, University of Auckland, Dunedin, New Zealand.
  • Drown J; Dunedin School of Medicine, University of Otago, Dunedin, New Zealand.
  • Taylor S; School of Medical Sciences, University of Auckland, Dunedin, New Zealand.
  • Wei J; Counties Manukau Health Laboratory Services, Dunedin, New Zealand.
  • Collins J; Department of Renal Medicine, Auckland District Health Board, Dunedin, New Zealand.
  • Thomas MG; Department of Renal Medicine, Auckland District Health Board, Dunedin, New Zealand.
Nephrology (Carlton) ; 24(7): 744-750, 2019 Jul.
Article em En | MEDLINE | ID: mdl-30129136
AIM: For patients requiring haemodialysis, the risk of Staphylococcus aureus disease is higher in those colonized and persists while the person requires haemodialysis, necessitating frequent decolonization. However, the duration of successful decolonization is not known. This study aimed to determine the duration of efficacy of decolonization in intermittent and persistent S. aureus carriers requiring haemodialysis using two decolonization strategies. METHODS: We screened 100 outpatients requiring haemodialysis for S. aureus carriage and then decolonized 14 intermittent carriers and 18 persistent carriers. Participants were invited to undertake two decolonization attempts, using systemic or topical antibiotics 12 weeks apart. Nasal swabs were taken weekly to determine the duration of successful decolonization. RESULTS: Decolonization was successful in 24/32 (75%) participants and the median duration of decolonization was 35 days (95% confidence interval (CI) 11-59). The median duration of S. aureus decolonization was significantly shorter for persistent carriers (19 days, 95% CI 13-25 days) in comparison with intermittent carriers (70 days, 95% CI 61-79 days; P < 0.01). 28/52 (54%) post-decolonization surveys indicated that they would use the treatment again, 14/52 (27%) surveys indicated that they would not use the treatment again, and 10/52 (19%) were undecided. 16/53 (30%) decolonization attempts resulted in an adverse drug reaction. CONCLUSION: Staphylococcus aureus decolonization using topical or systemic treatments was successful for many haemodialysis patients, and provided a month free of S. aureus colonization. Although decolonization treatment provided a shorter duration of success for persistent carriers in comparison with intermittent carriers, persistent carriers are likely to gain the most from effective decolonization strategies.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Staphylococcus aureus / Portador Sadio / Diálise Renal / Antibacterianos / Mucosa Nasal Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Staphylococcus aureus / Portador Sadio / Diálise Renal / Antibacterianos / Mucosa Nasal Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article